Eur Rev Med Pharmacol Sci 2022; 26 (9): 3171-3178DOI: 10.26355/eurrev_202205_28734 The effect of statin on major adverse cardiovascular events and mortality in patients with rheumatoid arthritis – a systematic review and meta-analysis A.R. Rahmadi, R. Pranata, W.M. Raffaello, E. Yonas, M.P. Ramadhian, M.R.R. Natadikarta, M.R. Akbar Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (6): 2025-2035DOI: 10.26355/eurrev_202203_28351 Micronutrients deficiencies in patients with spondylarthritis: the potential immunometabolic crosstalk in disease phenotype P. Triggianese, F. Caso, D. Della Morte, A. D’Antonio, S. Ferrigno, M. Fatica, L. Costa, M. Tasso, P. Conigliaro, A. Bergamini, M.S. Chimenti Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (2): 585-590DOI: 10.26355/eurrev_202201_27885 Height associated with different clinical expressions in primary antiphospholipid syndrome female patients J. Freire Carvalho, M.B. Pereira Torales, M.I. Figueiredo Sousa, T. Larocca Skare Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (1): 54-58DOI: 10.26355/eurrev_202201_27747 Real-life experience of edoxaban treatment for venous thromboembolism (VTE)/pulmonary embolism (PE) in patients with isolated positive Lupus Anticoagulant (LAC) during the COVID-19 pandemic lockdown in Italy L. Puccetti, V. Sammartano, P. Calzoni, F. Bacchiarri, A. Santoni, D. Fineschi, M. Bocchia Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (1): 32-36DOI: 10.26355/eurrev_202201_27744 Discoid lupus in antiphospholipid syndrome: case description and literature review J. Freire de Carvalho, T. Larocca Skare, C. Figueiredo, P.R. Criado Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (24): 7840-7846DOI: 10.26355/eurrev_202112_27631 Pain as a mediator in the temperament-alexithymia relationship in individuals suffering from rheumatoid arthritis M. Ziarko, B. Grobelny, D. Sikorska, A. Jasielska, A. Maseda, J. Millán-Calenti, W. Samborski, E. Mojs, A. Piglowska Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (24): 7833-7839DOI: 10.26355/eurrev_202112_27630 Effectiveness and adverse effects of anakinra in treatment of rheumatoid arthritis: a systematic review M.K. Bedaiwi, I. Almaghlouth, M.A. Omair Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (22): 7022-7029DOI: 10.26355/eurrev_202111_27252 Efficacy of ultramicronised diclofenac in patients with osteoarthritis – systematic review with network meta-analysis G.C. de Campos, E. de Almeida Macedo, A.M. Kummer, M. Papaleo Rosim, M. Millan Fachi, L.L. Auletta Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (22): 7014-7021DOI: 10.26355/eurrev_202111_27251 Association between rheumatoid factors and proinflammatory biomarkers with implant health in rheumatoid arthritis patients with dental implants A. Alenazi Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (22): 7005-7013DOI: 10.26355/eurrev_202111_27249 Venous thromboembolism risk in rheumatoid arthritis patients: a systematic review and updated meta-analysis L.-J. Hu, B. Ji, H.-X. Fan Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (18): 5755-5765DOI: 10.26355/eurrev_202109_26793 Biologics for psoriatic arthritis: network meta-analysis in review A. Migliore, G. Gigliucci, D. Birra, R. Saporito, L. Cicerchia, U. Massafra, D. Integlia, M. Cassol Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (18): 5581-5583DOI: 10.26355/eurrev_202109_26777 Vitamin D insufficiency is very frequent and linked to inflammatory biomarkers in relapsing polychondritis J. Freire de Carvalho, M.F. Vicente Matias, L.M. Carvalho Bastos, R.P. Correia de Araujo Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (16): 5241-5247DOI: 10.26355/eurrev_202108_26538 A cross-sectional study on clinical characteristics of Saudi axial spondylarthritis: preliminary results M.K. Bedaiwi, R.F. AlRasheed, A. Bin Zuair, E.M. Alqurtas, M.O. Baeshen, M.A. Omair Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (14): 4687-4692DOI: 10.26355/eurrev_202107_26379 Iguratimod attenuates general disease activity and improves lung function in rheumatoid arthritis-associated interstitial lung disease patients P. Shu, S.-Q. Shao, X.-N. Cai, D.-M. Zhou, H. Ma, L. Lu, H.-Q. Yin, S.-L. Yin Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (12): 4325-4335DOI: 10.26355/eurrev_202106_26140 Iron metabolism in patients with rheumatoid arthritis W. Tański, M. Chabowski, B. Jankowska-Polańska, E.A. Jankowska Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (9): 3416-3424DOI: 10.26355/eurrev_202105_25821 Impact of biologic disease-modifying antirheumatic drugs on fracture risk in patients with rheumatoid arthritis: a systematic review and meta-analysis F. Shao, H.-C. Li, M.-J. Wang, C.-M. Cui Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (3): 1425-1435DOI: 10.26355/eurrev_202102_24850 Impact of miR-155 (rs767649 A>T) and miR-146a (rs57095329 A>G) polymorphisms in System Lupus Erythematosus susceptibility in an Egyptian cohort S.R. Mohammed, O.G. Shaker, A.A. Mohammed, N.A. Fouad, H.A. Hussein, N.A. Ahmed, O.M. Ahmed, D.Y. Ali, M.M. Mohamed, A.A. Ibrahim Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (2): 574-575DOI: 10.26355/eurrev_202101_24611 High frequency of vitamin D insufficiency in polymyalgia rheumatica and giant cell arteritis: preliminary results J.F. de Carvalho, Y. Shoenfeld Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (1): 56-64DOI: 10.26355/eurrev_202101_24347 Differences in biologics for treating ankylosing spondylitis: the contribution of network meta-analysis A. Migliore, G. Gigliucci, D. Integlia, N. Isailovic, B. Frediani Free PDF Download
Eur Rev Med Pharmacol Sci 2020; 24 (22): 11675-11682DOI: 10.26355/eurrev_202011_23812 MiR-34a-5p inhibits fibroblast‑like synoviocytes proliferation via XBP1 A.-F. Song, L. Kang, Y.-F. Wang, M. Wang Free PDF Download